NEXThaleR Real-world Study Assessing the EffectivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs in COPD Patients
N/A
The goal of this observational study is to measure improvement in health re...
Status
Completed
Location
Albert Schweitzer Kórház és Rendelőintézet Tüdőbeteggondozó
Start Date
2023-03-29
Trial ID
NCT05743608
Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®
PHASE1
The study is being conducted to compare the pharmacokinetic (PK) of BDP (an...
Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study
N/A
This is an observational, prospective, multicentric, cohort study conducted...
Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease
PHASE4
This will be a phase IV, open label, multicenter, randomized pragmatic stud...